Legislature(2017 - 2018)SENATE FINANCE 532
04/03/2018 01:30 PM Senate FINANCE
Note: the audio ![]()
and video ![]()
recordings are distinct records and are obtained from different sources. As such there may be key differences between the two. The audio recordings are captured by our records offices as the official record of the meeting and will have more accurate timestamps. Use the icons to switch between them.
| Audio | Topic |
|---|---|
| Start | |
| SB198 | |
| HB76 | |
| HB128 | |
| SB142 | |
| Adjourn |
* first hearing in first committee of referral
+ teleconferenced
= bill was previously heard/scheduled
+ teleconferenced
= bill was previously heard/scheduled
| + | HB 286 | TELECONFERENCED | |
| += | SB 142 | TELECONFERENCED | |
| + | TELECONFERENCED | ||
| += | HB 76 | TELECONFERENCED | |
| += | HB 128 | TELECONFERENCED | |
| += | SB 198 | TELECONFERENCED | |
SENATE BILL NO. 198
"An Act relating to a study of the effectiveness and
cost of providing long-acting reversible contraception
to women with substance abuse disorders."
1:36:50 PM
HEATHER CARPENTER, STAFF, SENATOR KELLY, stated the intent
of the bill. She shared that the bill was specifically an
outcome of the bill sponsor's efforts to eradicate fetal
alcohol spectrum disorder (FASD), and would also address
the population that was affected by neonatal abstinence
syndrome (NAS). She stated that it would be a three-year
study conduced by the University of Alaska Anchorage Center
for Alcohol and Addiction Studies.
Vice-Chair Bishop addressed the fiscal note.
Co-Chair MacKinnon announced that the fiscal note would be
forthcoming.
MOVED to REPORT SB 198 from committee with individual
recommendation and attached fiscal note. There being NO
OBJECTION, it was so ordered.
SB 198 was REPORTED out of committee with a "do pass"
recommendation and with one new fiscal impact note from the
University of Alaska.
1:40:17 PM
AT EASE
1:41:45 PM
RECONVENED